Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Nuclease-resistant phosphorothioate analogs of certain oligodeoxynucleotides have been tested in vitro as antiviral agents against human immunodeficiency virus (HIV) in human T cells. Phosphorothioate analogs complementary to HIV sequences, as well as noncomplementary analogs including homooligomers, exhibited potent antiviral activity. The antiviral activity was related to the base composition of the analogs, and longer phosphorothioates were more effective than shorter ones. A 28-mer phosphorothioate oligodeoxycytidine (S-dC28) at a concentration of 1 microM exhibited potent antiviral activity and inhibited de novo viral DNA synthesis as shown by Southern blot analysis. However, S-dC28 failed to inhibit gag expression in chronically infected T cells assessed by immunofluorescent assay at concentrations up to 25 microM. An N3-methylthymidine-containing phosphorothioate analog, which does not hybridize efficiently in vitro to complementary normal DNA, showed no antiviral activity. A 14-mer phosphorothioate oligodeoxycytidine (S-dC14) synergistically enhanced the antiviral activity of 2',3'-dideoxyadenosine, an anti-HIV nucleoside. Therefore, phosphorothioate analogs of oligodeoxynucleotides could represent a unique class of experimental therapeutic agents against the acquired immunodeficiency syndrome and related diseases. However, their mechanism of action is likely to be complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,039
Self-citationInhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.
Stephenson, M. L., & Zamecnik, P. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.285 · Cited by 906
Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)
Arya, S. K., Guo, C., Josephs, S. F., & Wong-Staal, F. (1985) · Science · doi:10.1126/science.2990040 · Cited by 858
Eckstein, F. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.002055 · Cited by 849
Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C., & Wong-Staal, F. (1986) · Cell · doi:10.1016/0092-8674(86)90062-0 · Cited by 669
A second post-transcriptional trans-activator gene required for HTLV-III replication
Sodroski, J., Goh, W. C., Rosen, C., Dayton, A., Terwilliger, E., & Haseltine, W. (1986) · Nature · doi:10.1038/321412a0 · Cited by 631
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication
Dayton, A. (1986) · Cell · doi:10.1016/0092-8674(86)90017-6 · Cited by 621
Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation.
Paterson, B. M., Roberts, B. E., & Kuff, E. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4370 · Cited by 536
Zamecnik, P. C., Goodchild, J., Taguchi, Y., & Sarin, P. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4143 · Cited by 400
Constitutive and Conditional Suppression of Exogenous and Endogenous Genes by Anti-Sense RNA
Izant, J. G., & Weintraub, H. (1985) · Science · doi:10.1126/science.2990048 · Cited by 336
Smith, C. C., Aurelian, L., Reddy, M. P., Miller, P. S., & Ts'o, P. O. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2787 · Cited by 297
α-Oligodeoxynucleotide stability in serum, subcellular extracts and culture media
Bacon, T. A., Morvan, F., Rayner, B., Imbach, J.-L., & Wickstrom, E. (1988) · Journal of Biochemical and Biophysical Methods · doi:10.1016/0165-022x(88)90065-6 · Cited by 255
THE EFFECT OF SUBSTITUENTS ON THE HYDROGEN BONDING OF ADENINE AND URACIL DERIVATIVES
Kyogoku, Y., Lord, R. C., & Rich, A. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.57.2.250 · Cited by 228
Mitsuya, H., Jarrett, R. F., Matsukura, M., Di Marzo Veronese, F., DeVico, A. L., Sarngadharan, M. G., Johns, D. G., Reitz, M. S., & Broder, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2033 · Cited by 203
Self-citationLaPlanche, L. A., James, T. L., Powell, C., Wilson, W. D., Uznański, B., Stec, W. J., Summers, M. F., & Zon, G. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.22.9081 · Cited by 80
Self-citationAIDS, modern concepts and therapeutic challenges
Broder, S. E. (1987) · DigitalGeorgetown (Georgetown University Library) · Cited by 62
Self-citationThe antiviral activity of thiophosphate-substituted polyribonucleotides in vitro and in vivo
Clercq, E. D., Eckstein, F., Sternbach, H., & Merigan, T. C. (1970) · Virology · doi:10.1016/0042-6822(70)90285-0 · Cited by 57
Cited by
The current landscape of nucleic acid therapeutics
Kulkarni, J. A., Witzigmann, D., Thomson, S. B., Chen, S., Leavitt, B. R., Cullis, P. R., & van der Meel, R. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00898-0 · Cited by 1,371
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Overcoming cellular barriers for RNA therapeutics
Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Metadata
- Authors
- Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J. S., & Broder, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1987-11
- Volume
- 84
- Issue
- 21
- Pages
- 7706-7710
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2022013776
- Cited by
- 533
- References
- 19
- FWCI
- 29.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.